Page results
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
The National Hospital for Neurosurgery at Cleveland Street opened its doors to patients on 4 April 2016. This brand new centre was developed to provide a new home for our Pain Management Centre, a nationally recognized centre of excellence for people with longstanding pain. Set over two floors the centre has group rooms and consulting clinic rooms as well as procedure rooms.Some multiple sclerosis clinics and outpatient appointments for the National Prion Clinic are also held at the centre.
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
-
This patient information provides possible explanations for the causes of long COVID.
-
The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, is the UK's largest dedicated neurological and neurosurgical hospital. It provides comprehensive services for the diagnosis, treatment and care of all conditions that affect the brain, spinal cord, peripheral nervous system and muscles. Services include specialist neurosurgery, a brain tumour unit, the Hyper-acute Stroke Unit (HASU), an acute brain injury unit, the National Prion Clinic, a pioneering neuro-rehabilitation unit, the UK's first interventional MRI scanner, the largest specialised neurosurgical ITU and the only neuromedical ITU in the country. Together with its neighbour, the UCL Queen Square Institute of Neurology, it is a major international centre for research and training.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
This patient information is intended to help patients suffering from long COVID to better manage and understand their fatigue.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
The Royal London Hospital for Integrated Medicine (RLHIM) is a centre for evidence-based practice, education and research, specialising in chronic and complex medical conditions. Our mission is to provide a person-centred, holistic approach, including self-care, in order to help people with chronic and complex medical conditions live well and feel better. Our approach considers the whole person and their environment in the quest for optimal health and wellbeing. In order to achieve this, we provide a combination of lifestyle strategies, medical, physical and psychological treatment, as well as advice on safe and appropriate use of complementary therapies. We also deliver and encourage self-care approaches which can continue to be used by patients after discharge. All RLHIM services are outpatient-based and are staffed by experienced healthcare professionals.
File results
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage
-
FOI/2023/0681 - Patient friends and family test supplier
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)
-
FOI/2023/0686 - Hysteroscopy Inpatient and Outpatient pathways
-
FOI/2023/0687 - Information Governance pay grades
-
FOI/2023/0689 - Access to digital test results for patients
-
FOI/2023/0691 - Integrated medicine
-
FOI/2023/0692 - Trust's Five year strategy spend